Structural and Biochemical Analysis of the Dual Inhibition of MG-132 against SARS-CoV-2 Main Protease (Mpro/3CLpro) and Human Cathepsin-L
After almost two years from its first evidence, the COVID-19 pandemic continues to afflict people worldwide, highlighting the need for multiple antiviral strategies. SARS-CoV-2 main protease (Mpro/3CLpro) is a recognized promising target for the development of effective drugs. Because single target...
Guardado en:
Autores principales: | Elisa Costanzi, Maria Kuzikov, Francesca Esposito, Simone Albani, Nicola Demitri, Barbara Giabbai, Marianna Camasta, Enzo Tramontano, Giulia Rossetti, Andrea Zaliani, Paola Storici |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/402a115ac6144f37ac9ec633532be974 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Natural Products-Based Drug Design against SARS-CoV-2 Mpro 3CLpro
por: Rai C. Silva, et al.
Publicado: (2021) -
Investigation of Thiocarbamates as Potential Inhibitors of the SARS-CoV-2 Mpro
por: Katarzyna Papaj, et al.
Publicado: (2021) -
SECONDARY METABOLITES FROM PACHYSTROMA LONGIFOLIUM (NEES) I. M. JOHNST (EUPHORBIACEAE) AND EVALUATION OF ITS EXTRACTS AS CATHEPSINS INHIBITORS
por: GALVÃO,DAYANE DE CÁSSIA, et al.
Publicado: (2017) -
Cysteine Cathepsins and Matrix Metalloproteases Among Breast Cancer Patients
por: Tsegaye S, et al.
Publicado: (2021) -
POTENTIAL OF CURATELLA AMARICANA L. AGAINST SARS-COV2: BIOAVAILABILITY, MOLECULAR SIMILARITY AND MOLECULAR DOCKING BETWEEN SECONDARY METABOLITES AND PROTEASE TYPE 3-CHYMOTRYPSIN (3CLPRO)
por: Marcano,Emildo, et al.
Publicado: (2021)